VEGF could promote FOXP3+ Treg cell migration and its immunosuppressive function, but the detailed mechanisms underlying VEGFR blocking therapy and tumour-infiltrating FOXP3+ Treg cells reduction are still unclear (148–150). The gene discussed is KDR; the disease is neoplasm.